Most U.S. Adults Unaware of Forever Chemicals
TUESDAY, Dec. 19, 2023 (HealthDay News) -- Three-quarters of U.S. adults do not know what forever chemicals are, according to a study published online Nov. 16 in PLOS ONE.T. Allen Berthold,...
TUESDAY, Dec. 19, 2023 (HealthDay News) -- Three-quarters of U.S. adults do not know what forever chemicals are, according to a study published online Nov. 16 in PLOS ONE.T. Allen Berthold,...
FRIDAY, Dec. 15, 2023 (HealthDay News) -- Postoperative atrial fibrillation (POAF) is associated with an increased rate of neurologic events and worse long-term survival, according to a stu...
THURSDAY, Dec. 14, 2023 (HealthDay News) -- Most patients with type 2 diabetes initiating antidiabetic medication (ADM) experience treatment modification within one year, according to a stu...
THURSDAY, Dec. 14, 2023 (HealthDay News) -- Senior physicians treat fewer traditionally underserved patients than their junior colleagues within the same practices, according to a research ...
WEDNESDAY, Dec. 13, 2023 (HealthDay News) -- Use of second-line noninsulin antidiabetic medications (ADMs) is increasing for type 2 diabetes (T2D) in pregnancy, but use is not associated wi...
WEDNESDAY, Dec. 13, 2023 (HealthDay News) -- According to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare...
TUESDAY, Dec. 12, 2023 (HealthDay News) -- Three-month outcomes are similar with medical and surgical management of pituitary apoplexy (PA), according to a study recently published in the J...
TUESDAY, Dec. 12, 2023 (HealthDay News) -- For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a ...
TUESDAY, Dec. 12, 2023 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends intensive behavioral interventions for children and teenagers with a high body mass in...
MONDAY, Dec. 11, 2023 (HealthDay News) -- For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for col...
MONDAY, Dec. 11, 2023 (HealthDay News) -- Withdrawing tirzepatide after 36 weeks is associated with regain of lost weight, while weight loss is maintained with continued treatment, accordin...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inq...
“If hemoglobin is low, especially if they are all in the anemic range, fracture risk should be considered,” says Mattias Lorentzon, MD, PhD. ...
THURSDAY, Dec. 7, 2023 (HealthDay News) -- Minority populations will benefit much more than the U.S. White adult population from antitobacco regulations that reduce smoking, according to a ...
THURSDAY, Dec. 7, 2023 (HealthDay News) -- Daily baricitinib treatment over 48 weeks preserves β-cell function in patients with type 1 diabetes diagnosed recently, according to a study pub...
THURSDAY, Dec. 7, 2023 (HealthDay News) -- In a push for lower drug prices, the Biden administration is warning pharmaceutical companies that it might use its authority to cancel patent pro...
THURSDAY, Dec. 7, 2023 (HealthDay News) -- Intense lobbying from the tobacco industry has led the Biden administration to again delay enacting a ban on menthol cigarettes. Along with that p...
WEDNESDAY, Dec. 6, 2023 (HealthDay News) -- Eli Lilly has announced that its newly approved weight-loss medication, Zepbound, is now available for patients to take."Today opens another chap...
WEDNESDAY, Dec. 6, 2023 (HealthDay News) -- Minorities often feel a deep sense of dread before doctor appointments, and some even try to dress especially well for their visit to try and war...
WEDNESDAY, Dec. 6, 2023 (HealthDay News) -- Earlier age at menarche is associated with type 2 diabetes risk among women younger than 65 years, according to a study published online Dec. 5 i...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.